Drug Information Analysis Service

Porter JM River SP Anderson CJ Baur EM . Evaluation and management of patients with Raynaud's syndrome. Am J Surg 1981; 142: 183–9.

Pathophysiology of Raynaud's phenomenon. Br Med J 1980; 281: 1027–8.

Rodeheffer RJ Rommer JA Wiggley F Smith CR . Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon. N Engl J Med 1983; 308: 880–3.

Smith CD McKendry RJ . Controlled trial of nifedipine in the treatment of Raynaud's phenomenon. Lancet 1982; 2: 1299–1301.

Kahan A Weber S Amor B Saporta L Hodara M . Nifedipine and Raynaud's phenomenon (letter). Ann Intern Med 1981; 94: 546.

Kinney EL Nicholas GG Gallo J Pontoriero C Zelis R . The treatment of severe Raynaud's phenomenon with verapamil. J Clin Pharmacol 1982; 22: 74–8.

Nielsen SL Vitting K Rasmussen K . Prazosin treatment of primary Raynaud's phenomenon. Eur J Clin Pharmacol 1983; 24: 421–3.

Appleby BR . Raynaud's phenomenon. Med J Aust 1978; 2: 437–9.

Waldo R . Prazosin relieves Raynaud's vasospasm. JAMA 1979; 241: 1037.

Coffman JD . Vasodilator drugs in peripheral vascular disease. N Engl J Med 1979; 300: 713–7.

Delgado-Escueta AV Wasterlain C Treiman DM Porter RJ . Current concepts in neurology. Management of status epilepticus. N Engl J Med 1982; 306: 1337–40.

Tehrani JB Cavanaugh A . Diazepam infusion in the treatment of tetanus (letter). Drug Intell Clin Pharm 1977; 11: 491.

Langdon DE Harlan JR Bailey RL . Thrombophlebitis with diazepam used intravenously (letter). JAMA 1983; 223: 184–5.

Wehlaze DF . Diazepam phlebitis (letter). JAMA 1973; 224: 128–9.

Roche package insert. Valium (diazepam). Roche Products, Inc., 1982.

Khalid SM Schulz H . The treatment and management of emergency status epilepticus. Epilepsia 1976; 17: 73–6.

Baskett TF Bradford CR . Acute management of severe preeclampsia. Can Med Assoc J 1973; 109: 1209–11.

Stoebner RC Kiser RW Decherd JF Perry JE . Diazepam (Valium) in the treatment of tetanus: A report of five cases. South Med J 1970; 63: 445–7.

Eliot BW Hill JG Cole AP Hailey DM . Continuous pethidine-diazepam infusion during labor and its effects on the newborn. Br J Obstet Gynaecol 1975; 82: 126–31.

Dundee JW Haslett WHK . The benzodiazepines: A review of their actions and uses relative to anaesthetic practice. Br J Anaesth 1970; 42: 217–34.

McClean WM . Safety of diazepam infusion questioned (letter). Drug Intell Clin Pharm 1977; 11: 690.

Blackstone M Flaska L Poikomen J . Management of status epilepticus (letter). N Engl J Med 1982; 307: 1145.

Huber JW Raymond GG . Additional conclusions on diazepam injectable precipitate: GC-MC confirmation. Clin Toxicol 1979; 14: 439–44.

Jusko WJ Gretch M Gassett R . Precipitation of diazepam from intravenous preparations (letter). JAMA 1973; 225: 176.

Morris ME . Compatibility and stability of diazepam injection following dilution with intravenous fluids. Am J Hosp Pharm 1978; 35: 669–72.

Sokolski TD . Solutions and phase equilibria. In: Hoover JE , ed. Remington's pharmaceutical sciences. 15th ed. Eaton, PA: Mack Publishing Co., 1975: 229–54.

Newton DW Driscoll DF Goudereau JL Rantanamaneichatara S . Solubility characteristics of diazepam in aqueous admixture solutions: Theory and practice. Am J Hosp Pharm 1981; 38: 179–82.

Mason NA Cline S Hyneck ML Berardi RR Ho NFH Flynn GL . Factors affecting diazepam infusion: Solubility, administration-set composition, and flow rate. Am J Hosp Pharm 1981; 38: 1449–54.

Cloyd JC . Diluting diazepam injection (letter). Am J Hosp Pharm 1981; 38: 32.

Cloyd JC Vezeua C Miller KW . Availability of diazepam from plastic containers. Am J Hosp Pharm 1980; 37: 492–6.

Parker WA Morris ME Shearer CA . Incompatibility of diazepam injection in plastic intravenous bags. Am J Hosp Pharm 1979; 36: 505–7.

Kowaluk EA Roberts MS Polack AE . Factors affecting the availability of diazepam stored in plastic bags and administered through intravenous sets. Am J Hosp Pharm 1983; 40: 417–23.

Smith A Bird G . The compatibility of diazepam with infusion fluids and their containers. J Clin Hosp Pharm 1982; 7: 181–6.

Yliruusi JK Sothmann AG Laine RH Rajasilta RA Kristoffersson ER . Sorptive loss of diazepam and nitroglycerin from solutions to three types of containers. Am J Hosp Pharm 1982; 39: 1018–21.

Parker WA MacCara ME . Compatibility of diazepam with intravenous fluid containers and administration sets. Am J Hosp Pharm 1980; 37: 496–500.

MacKichan J Duffner PK Cohen ME . Adsorption of diazepam to plastic tubing. N Engl J Med 1979; 301: 332–3.

Dasta JF Brier K Schonfield S . Loss of diazepam to drug delivery systems (letter). Am J Hosp Pharm 1980; 37: 1176–8.

McFarlin D McFarland H . Multiple sclerosis. Parts I and II. N Engl J Med 1982; 307: 1183–8, 1246–51.

Rose AS Kuzma JW Kurtzke JF Namerow NS Sibley WA . Cooperative study in the evaluation of therapy in multiple sclerosis—ACTH vs. placebo: Final report. Neurology 1970; 20 (suppl): 1–59.

Ellison G Myers L . A review of systemic nonspecific immunosuppressive treatment of multiple sclerosis. Neurology 1978; 28: 132–9.

Ellison G Myers L . Immunosuppressive drugs in multiple sclerosis: Pro and con. Neurology 1980; 30: 28–32.

Gonsette RE Demonty L Delmotte P . Intensive immunosuppression with cyclophosphamide in multiple sclerosis. J Neurol 1977; 214: 173–81.

Girard P Aimard G Pellet H . Immunodepressive therapy in neurology. Nouv Presse Med 1967; 75: 967–8.

Millac P Miller H . Cyclophosphamide in multiple sclerosis (letter). Lancet 1969; 1: 783.

Drachman DA Paterson PY Schmidt RT Spehlman RF . Cyclophosphamide in exacerbations of multiple sclerosis. J Neurol Neurosurg Psych 1975; 38: 592–7.

Hauser SL Dawson DM Lehrich JR Intensive immunosuppression in progressive multiple sclerosis. N Engl J Med 1983; 308: 173–80.

Hommes OR Lamers KJB Reekers P . Effect of intensive immunosuppression on the course of chronic progressive multiple sclerosis. J Neurol 1980; 223: 177–90.